Articles From: BioMed Realty Launches New Mobile Application To Provide An Immersive Experience Of Its New Life Science Real Estate Projects to Cognex to Present at Robert W. Baird Industrial Conference


New iPad® and iPhone® Application Provides Brokers and Life Science Companies with Detailed Insight Regarding BioMed Realty's New Development Projects SAN DIEGO , Oct.
Sign-up for BioMed Realty Launches New Mobile Application To Provide An Immersive Experience Of Its New Life Science Real Estate Projects investment picks
HUNTINGTON BEACH, Calif., Oct.
Sign-up for BJ's Restaurants, Inc. Announces Date for Third Quarter 2014 Earnings Release and Conference Call investment picks
The Board of Directors of Full House Resorts, Inc. (NASDAQ:FLL) comments on the public announcement on October 9, 2014 made by dissident minority stockholders regarding their request to call a special meeting to appoint certain individuals to the Company’s board of directors and make changes to the Company’s bylaws.
Sign-up for Board of Directors of Full House Resorts, Inc. Comments on Stockholder Proposal and Strategic Alternatives investment picks
2014/10/13
Machinists fabricate first 737 MAX fuselage stringer AUBURN, Wash.
Sign-up for Boeing Begins Production on First 737 MAX Parts investment picks
MILWAUKEE , Oct.
Sign-up for Briggs & Stratton Corporation to Announce Fiscal 2015 First Quarter Results investment picks
Bristol-Myers Squibb Company (NYSE:BMY), Pharmacyclics, Inc. (NASDAQ:PCYC), and Janssen Research & Development, LLC announced today they have entered into a clinical trial collaboration agreement to evaluate the safety, tolerability and preliminary efficacy of Bristol-Myers Squibb’s investigational PD-1 immune checkpoint inhibitor OPDIVO ® (nivolumab) in combination with IMBRUVICA ® (ibrutinib), an oral Bruton's tyrosine kinase (BTK) inhibitor co-developed and co-marketed by Pharmacyclics and Janssen.
Sign-up for Bristol-Myers Squibb, Pharmacyclics and Janssen Announce Clinical Collaboration to Evaluate OPDIVO® (nivolumab) and IMBRUVICA®(ibrutinib) in Non-Hodgkin Lymphoma investment picks
BTIG analyst Richard Greenfield on Monday raised his rating on Netflix Inc. (NFLX) to buy from neutral, with a target price of $600 a share on the video-streaming company's stock.
Sign-up for BTIG raises Netflix rating to buy investment picks
2014/10/13
LOS ANGELES , Oct.
Sign-up for Caesarstone Launches Calacatta Nuvo, Available In The United States October 2014 investment picks
2014/10/13
CAMBRIDGE and LONDON , Oct.
Sign-up for Cambridge University and Newton Investment Management announce partnership on long-horizon investing investment picks
2014/10/13
By Andria Cheng, MarketWatch NEW YORK (MarketWatch) -- Investors on Monday voted yes to J.C. Penney's (JCP) appointment of Home Depot's Marvin Ellison to succeed CEO Mike Ullman next August, sending the company's stock up 5% after five straight sessions of decline.
Sign-up for Can J.C. Penney's new CEO make a difference? investment picks
By Dana Mattioli, Liz Hoffman and David George-Cosh Canadian Pacific Railway Ltd.
Sign-up for Canadian Pacific approached CSX about merger deal investment picks
> The collaboration will result in a novel, next-generation sequencing based panel for the improved diagnosis and prognosis of Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) > Nearly 100,000 people are living with MDS in the US, and both MDS and AML are increasing globally in incidence and prevalence.
Sign-up for Cancer Genetics Inc. Announces Collaboration With Leading Oncology Researchers at Columbia University to Identify Genomic Signatures, Biomarkers and Novel Treatments for MDS and AML investment picks
2014/10/13
Canon Information and Imaging Solutions, Inc., a wholly-owned subsidiary of Canon U.S.A., Inc., today announced it has launched XS Quoter on Salesforce AppExchange, empowering businesses to connect with customers, partners and employees in a whole new way.
Sign-up for Canon Announces XS Quoter on Salesforce AppExchange, the World’s Leading Enterprise Apps Marketplace investment picks
Capstead Mortgage Corporation (NYSE: CMO ) announced today that it will release its third quarter 2014 results following the close of trading on the New York Stock Exchange on Wednesday, October 29, 2014.
Sign-up for Capstead Mortgage Corporation Schedules Third Quarter 2014 Earnings Release and Conference Call investment picks
By Tomi Kilgore, MarketWatch Shares of auto retailers took a beating Monday following a profit warning by Lithia Motors, less than two weeks after Warren Buffett sparked a broad rally by buying into the sector.
Sign-up for Car dealer shares take a dive after Lithia's profit warning investment picks
Care.com, Inc. (NYSE: CRCM), the world’s largest online destination for finding and managing family care, will announce its financial results for the third quarter ended September 27, 2014 on Thursday, October 30, 2014.
Sign-up for Care.com to Announce Third Quarter 2014 Earnings Results on October 30, 2014 investment picks
CLEVELAND , Oct.
Sign-up for CBIZ To Webcast 2014 Third-Quarter Results Conference Call investment picks
RANCHO CORDOVA, Calif.
Sign-up for Cesca Therapeutics Announces Agreement With New York Upstate Cord Blood Bank investment picks
ChannelAdvisor Corporation (NYSE: ECOM), a leading provider of cloud-based e-commerce solutions that enable retailers and manufacturers to increase global sales, today announced that it will release its third quarter 2014 financial results for the period ended September 30, 2014 after market close on Thursday, November 6, 2014.
Sign-up for ChannelAdvisor Announces Date of Third Quarter 2014 Financial Results, Conference Call and Webcast investment picks
Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services , today announced that the Company will webcast its third-quarter 2014 financial results conference call on Thursday, October 23, 2014 at 9:00 a.m. ET.
Sign-up for Charles River Associates (CRA) to Host Third-Quarter Fiscal 2014 Financial Results Conference Call on October 23 investment picks
DURHAM, N.C., Oct.
Sign-up for Chimerix to Webcast R&D Update on October 15th investment picks
2014/10/13
XI'AN, China , Oct.
Sign-up for China Green Agriculture Signed a Tripartite Cooperation Memorandum with Business Strategy Partners investment picks
2014/10/13
SHENZHEN, China , Oct.
Sign-up for China Information Technology, Inc. Appoints New Chief Financial Officer investment picks
2014/10/13
ZHANGZHOU, China , Oct.
Sign-up for China Zenix Auto Supplied Aluminum Wheels To CIMC-Chery Auto JV investment picks
2014/10/13
Millions of dollars each year are spent on diet and exercise websites and apps*, yet a surprisingly small percentage of Americans use them to improve their health, measure progress and achieve positive results, according to a 2014 U.S. national survey by Cigna (NYSE: CI). According to the survey, most of those who tried this year to improve their diet or fitness levels did so “on their own,” are still “working on it” (74 percent) and most blame themselves for a lack of will power (40 percent) or by being distracted (42 percent). They also say the best way to help them get on track, and stay there, is by positive reinforcement and rewards.
Sign-up for Cigna Introduces Cigna Health Matters -- a Comprehensive System to Improve and Sustain Your Health investment picks
Cloud Peak Energy Inc. (NYSE:CLD), one of the largest U.S. coal producers and the only pure-play Powder River Basin (“PRB”) coal company, plans to announce its third quarter and first nine months of 2014 financial results on October 29, 2014, after the markets close.
Sign-up for Cloud Peak Energy Inc. Announces Schedule for Third Quarter and First Nine Months of 2014 Results investment picks
SEATTLE, Washington and PALO ALTO, Calif., Oct.
Sign-up for Cloudera and EMC Launch Joint Solution for Seamless Integration Between EMC Isilon and Cloudera Enterprise Data Hub investment picks
Cognex Corporation (NASDAQ: CGNX) announced today that Richard A.
Sign-up for Cognex to Present at Robert W. Baird Industrial Conference investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: BioMed Realty Launches New Mobile Application To Provide An Immersive Experience Of Its New Life Science Real Estate Projects to Cognex to Present at Robert W. Baird Industrial Conference
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent